Joshua D Brandstadter, MD PhD MSc

faculty photo
Instructor A of Medicine
Department: Medicine

Contact information
Education:
BA (Molecular Biology & Biochemistry; Economics)
Wesleyan University, 2006.
MSc (Integrated Immunology)
University of Oxford, 2007.
MD-PhD (Medicine; Molecular Cancer Biology)
Duke University, 2015.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Castleman disease, histiocytic disorders, lymphoma, lymphoproliferative disorders

Description of Research Expertise

Castleman Disease, lymphoproliferative disorders, lymphoma, lymph node stromal cells, fibroblastic stromal cells

Selected Publications

Pierson SK, Lim MS, Srkalovic G, Brandstadter JD, Sarmiento Bustamante M, Shyamsundar S, Mango N, Lavery C, Austin B, Alapat D, Lechowicz MJ, Bagg A, Li H, Casper C, van Rhee F, Fajgenbaum DC.: Treatment Consistent with Idiopathic Multicentric Castleman Disease Guidelines is Associated with Improved Outcomes. Blood Adv Sep 2023.

Sarmiento Bustamante M, Shyamsundar S, Coren FR, Bagg A, Srkalovic G, Alapat D, van Rhee F, Lim MS, Lechowicz MJ, Brandstadter JD, Pierson SK, Fajgenbaum DC.: Ongoing symptoms following complete surgical excision in unicentric Castleman disease. Am J Hematol Aug 2023.

Brandstadter JD, Outen R, Maillard I.: Having it both ways: how STAT3 deficiency blocks graft-versus-host disease while preserving graft-versus-leukemia activity. J Clin Invest 133: e172251, Aug 2023.

Brandstadter JD, De Martin A, Lϋtge M, Ferreira A, Gaudette BT, Stanossek Y, Wang S, Gonzalez MV, Camiolo E, Wertheim G, Austin B, Allman D, Bagg A, Lim MS, Fajgenbaum DC, Aster JC, Ludewig B, Maillard I.: A novel cryopreservation and biobanking strategy to study lymphoid tissue stromal cells in human disease. Eur J Immunol Jun 2023.

De Martin A, Stanossek Y, Lütge M, Cadosch N, Onder L, Cheng HW, Brandstadter JD, Maillard I, Stoeckli SJ, Pikor NB, Ludewig B.: PI16(+) reticular cells in human palatine tonsils govern T cell activity in distinct subepithelial niches. Nat Immunol 2023.

Brandstadter JD, Fajgenbaum DC.: How we manage idiopathic multicentric Castleman disease. Clin Adv Hematol Oncol 2022.

Graniel JV, Bisht K, Friedman A, White J, Perkey E, Vanderbeck A, Moroz A, Carrington LJ, Brandstadter JD, Allen F, Shami AN, Thomas P, Crayton A, Manzor M, Mychalowych A, Chase J, Hammoud SS, Keegan CE, Maillard I, Nandakumar J.: Differential impact of a dyskeratosis congenita mutation in TPP1 on mouse hematopoiesis and germline. Life Sci Alliance 5: e202101208, Oct 2021.

van Rhee F, Oksenhendler E, Srkalovic G, Voorhees P, Lim M, Dispenzieri A, Ide M, Parente S, Schey S, Streetly M, Wong R, Wu D, Maillard I, Brandstadter J, Munshi N, Bowne W, Elenitoba-Johnson KS, Fössa A, Lechowicz MJ, Chandrakasan S, Pierson SK, Greenway A, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Chadburn A, Fajgenbaum DC.: International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv 4: 6039-6050, Dec 2020.

Bair SM, Brandstadter JD, Ayers EC, Stadtmauer EA.: Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy. Cancer 126: 1837-1855, Jan 2020.

Brandstadter JD, Maillard I.: Notch signalling in T cell homeostasis and differentiation. Open Biol 9: 190187, Nov 2019.

back to top
Last updated: 09/10/2023
The Trustees of the University of Pennsylvania